The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Extended follow-up results from the CheckMate 274 trial.
 
Matt D. Galsky
Stock and Other Ownership Interests - Rappta Therapeutics
Consulting or Advisory Role - Aileron Therapeutics; Astellas Pharma; AstraZeneca; Basilea; BioMotiv; Bristol-Myers Squibb; Dendreon; Dracen; Dragonfly Therapeutics; EMD Serono; Genentech; Gilead Sciences; GlaxoSmithKline; Incyte; Infinity Pharmaceuticals; Inovio Pharmaceuticals; Janssen; Lilly; Merck; Novartis; NuMab; Pfizer; Seagen; Silverback Therapeutics; Urogen pharma
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); Genentech/Roche (Inst); Janssen Oncology (Inst); Merck (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - METHODS AND COMPOSITIONS FOR TREATING CANCER AND RELATED METHODS. MOUNT SINAI SCHOOL OF MEDICINE July 2012 Application number: 20120322792
 
Alfred Alfred Witjes
Honoraria - Astellas Pharma; AstraZeneca; Beigene; Bristol-Myers Squibb/Pfizer; Ferring; Janssen; MSD; Nucleix
Consulting or Advisory Role - Asieris Pharmaceuticals; AstraZeneca; BeiGene; Bristol-Myers Squibb; Ferring; Janssen Oncology; MSD; oncodiag; photocure; Urogen pharma
 
Jürgen E. Gschwend
Honoraria - Bayer Schering Pharma; Bristol-Myers Squibb; Janssen-Cilag
Consulting or Advisory Role - Bayer Schering Pharma; Bristol-Myers Squibb; Janssen-Cilag
 
Michael Schenker
Research Funding - Abbvie; Amgen; Astellas Pharma; AstraZeneca; BeiGene; BIOVEN; Bristol-Myers Squibb; Clovis Oncology; Five Prime Therapeutics; Gilead Sciences; GlaxoSmithKline; Lilly; MSD; Mylan; Novartis; Pfizer/EMD Serono; Regeneron; Roche; Sanofi/Regeneron; Tesaro; Tesaro
Travel, Accommodations, Expenses - Bristol Myers Squibb
 
Begoña Pérez Valderrama
Honoraria - Astellas Pharma; Bayer; Bristol-Myers Squibb/Medarex; EUSA Pharma; Ipsen; Pfizer; Roche; Roche
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb/Medarex; MSD Oncology; Novartis
Travel, Accommodations, Expenses - Merck/Pfizer
 
Yoshihiko Tomita
Honoraria - Astellas Pharma; Bristol-Myers Squibb Japan; Chugai Pharma; Novartis; Ono Pharmaceutical
Consulting or Advisory Role - Eisai; Eisai; MSD; Ono Pharmaceutical
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Chugai Pharma (Inst); Eisai (Inst); MSD (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst); Takeda (Inst)
 
Aristotelis Bamias
Honoraria - Astellas Pharma; Bristol-Myers Squibb; Debiopharm Group; MSD; Sanofi
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Ferring; Ipsen; MSD; Pfizer; Roche
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Ipsen (Inst); Pfizer (Inst); Roche (Inst)
 
Thierry Lebret
Consulting or Advisory Role - Ipsen
Speakers' Bureau - Ferring
Travel, Accommodations, Expenses - Pfizer
 
Shahrokh F. Shariat
Stock and Other Ownership Interests - Seagen; UroGen pharma
Honoraria - Astellas Pharma; Bayer; Bristol-Myers Squibb; Cepheid; Dr. Wolff Group; Ferring; Ipsen; Janssen; MSD; Olympus; Pfizer; Pierre Fabre; Roche; Sanochemia; Sanofi; UroGen pharma
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; Cepheid; Ferring; Ipsen; Janssen; Lilly; MSD; Olympus; Pfizer; Pierre Fabre; Ribon Therapeutics; Roche; Sanochemia; Sanofi
Speakers' Bureau - Astellas Pharma; Bayer; Bristol-Myers Squibb; Cepheid; Ferring; Ipsen; Janssen; Lilly; MSD; Olympus; Pfizer; Pierre Fabre; Ribon Therapeutics; Roche; Sanochemia; Sanofi
Research Funding - Astellas Pharma; Bayer; Sanofi
Patents, Royalties, Other Intellectual Property - Patent US20030054419; Patent US20030235816; US07759077; US2003235816
 
Se Hoon Park
Honoraria - Merck; Ono Pharmaceutical; Pfizer
Consulting or Advisory Role - Janssen
Research Funding - Ono Pharmaceutical; Sanofi
 
Mads Agerbaek
No Relationships to Disclose
 
Gautam Gopalji Jha
Speakers' Bureau - AstraZeneca; Exelixis
 
Frank Stenner
Consulting or Advisory Role - Bristol-Myers Squibb/Roche; Ipsen; MSD; Novartis; Pfizer
Research Funding - BMS GmbH & Co. KG; Takeda
Travel, Accommodations, Expenses - BMS GmbH & Co. KG; Roche
 
Santanu Dutta
Employment - Bristol-Myers Squibb/Celgene
Stock and Other Ownership Interests - Bristol-Myers Squibb/Celgene
 
Federico Nasroulah
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Joshua Zhang
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Dean F. Bajorin
Honoraria - Bristol-Myers Squibb/Medarex
Consulting or Advisory Role - Bristol Myers Squibb Foundation; Merck
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); Novartis (Inst); Seattle Genetics/Astellas (Inst)